Create an Account
Welcome & Mission Statement
User Technical Support
Accreditation Legend
System Requirements
Point-of-Care Musculoskeletal Ultrasound for Bleed Detection in Joints and Muscle
Point-of-Care Musculoskeletal Ultrasound for Bleed Detection in Joints and Muscle

Point-of-Care Musculoskeletal Ultrasound for Bleed Detection in Joints and Muscle

To begin this activity, click the yellow "Select" button at the top right of the page.
Please read this page and scroll to the bottom to continue to the course.

Activity Description
This activity is a 1.5 hour presentation covering the basic concepts of bleed detection in joints and muscles using point-of-care musculoskeletal ultrasound.

Target Audience

This educational program is designed for physicians, physician assistants, nurse practitioners, nurses, and physical therapists involved and/or interested in MSKUS as point-of care imaging tool to assist with diagnosis and treatment of joint pains in people with hemophilia. Other healthcare professionals involved in hemophilia clinical care may benefit from this education program as well.

Method of Participation

The estimated time to complete this activity is 1 hour and 30 minutes. To obtain credit, participants should answer the brief pre-activity survey, view the presentation, answer the multiple-choice post test questions, and complete the evaluation form online to receive a certificate online immediately upon completion.

Educational Objectives

Following completion of this educational activity, learners should be able to

    Contrast ultrasound characteristics of intra-articular tissue and joint fluid or effusions
    Describe the difference between simple (non-bloody) and complex (bloody effusions) in hemophilic joints
    Visualize muscle bleeds and hematomas

Statement of Need
Musculoskeletal disease is common in hemophilia. Hemophilic arthropathy is a frequent and debilitating comorbidity. The clinical exam to diagnose and treat hemarthrosis, joint problems and musculoskeletal abnormalities is unreliable. There is an urgent medical need to teach MSKUS techniques to hemophilia providers for wide-spread use for diagnosis and management of hemophilic arthropathy.


The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
 The University of California, San Diego School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing this program. 

 For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 1.5 hours of credit and list "CME Category 1" as the provider number).

Release Date: January 22, 2018
Expiration Date: January 21, 2021


Course Director

Annette von Drygalski, MD, PharmD, RMSK
Associate Clinical Professor of Medicine
Director, Hemophilia & Thrombosis Treatment Center at UC San Diego Health
University of California, San Diego
San Diego, California

Balance and Objectivity of Content

It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker's outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.

The course director, faculty, review committee members, and project staff have indicated they have no financial relationships with commercial interests relevant to the content of this activity.

The CME staff, meeting planners, editorial staff, planning committee, and CME committee reviewers do not have any relevant financial relationships to disclose. 

Off-label Disclosure: This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product. 

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, San Diego.

Cultural Competency
This activity is in compliance with California Assembly Bill 1195 which requires CME courses with patient care components to include curriculum in the subjects of cultural and linguistic competencies. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language. Cultural and Linguistic Competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UC San Diego CME website at

This activity is supported by an educational grant from Pfizer

UC San Diego School of Medicine
9500 Gilman Drive, MC 0947, La Jolla, CA 92093-0947
Phone: (858) 534-3940 • Fax: (858) 534-1896
E-mail: • Website:

Type:     Internet Activity (Enduring Material)
70 Registered Users